tsamba_banner

nkhani

Kuchepetsa kulemera kwazinthu zopangira sermaglutide CAS 910463-68-2 msika wagloble

Msika wapadziko lonse wochepetsera thupi ukupitilira kukula ndikukula, ndikukula kufunikira kwa mayankho ogwira mtima komanso otetezeka.Mmodzi mwa osewera akulu pamsikawu ndi chopangira chochepetsa thupi semaglutide (CAS 910463-68-2).Semaglutide ndi glucagon-like peptide-1 (GLP-1) receptor agonist yomwe imagwiritsidwa ntchito pochiza matenda a shuga a 2 ndipo posachedwapa yalandira chidwi chifukwa cha kugwiritsidwa ntchito kwake pakuwongolera kulemera.

Semaglutide imagwira ntchito potengera zotsatira za GLP-1, mahomoni omwe amapezeka mwachilengedwe m'thupi omwe amathandiza kuwongolera kuchuluka kwa shuga m'magazi.Zasonyezedwa kuti zimachepetsa chilakolako ndi chakudya, zomwe zimapangitsa kuti anthu omwe ali ndi kunenepa kwambiri awonongeke.Izi zimapangitsa semaglutide kukhala njira yabwino kwa iwo omwe akufuna kukwaniritsa zolinga zawo zoonda.

Msika wapadziko lonse wopangira zopangira zowonda, kuphatikiza semaglutide, akuyembekezeka kuchitira umboni kukula kwakukulu m'zaka zikubwerazi.Zinthu monga kuchulukirachulukira kwa kunenepa kwambiri, kudziwitsa zambiri za kuwopsa kwa thanzi komwe kumakhudzana ndi kunenepa kwambiri, komanso kufunikira kwa mayankho ogwira mtima ochepetsa thupi ndikuyendetsa kukula kwa msika.

Makampani angapo opanga mankhwala akutenga nawo gawo pakupanga ndi kugulitsa semaglutide pakuwongolera kulemera.Novo Nordisk, mtsogoleri wapadziko lonse pazamankhwala a shuga, wapanga jakisoni wa semaglutide kamodzi pa sabata makamaka kuti achepetse thupi.Kampaniyo inachita mayesero ambiri azachipatala omwe amasonyeza chitetezo ndi mphamvu ya semaglutide polimbikitsa kuchepetsa thupi, ndi zotsatira zolimbikitsa.

Mu 2021, US Food and Drug Administration (FDA) idavomereza semaglutide kuti aziwongolera kulemera kwanthawi yayitali mwa akulu onenepa kapena onenepa kwambiri omwe ali ndi vuto limodzi lokhudzana ndi kulemera.Ichi ndi gawo lofunikira kwambiri pamsika wapadziko lonse lapansi wochepetsa thupi chifukwa ndi nthawi yoyamba kuti GLP-1 receptor agonist ivomerezedwe makamaka pakuwongolera kulemera.

Kuphatikiza pa United States, mayiko ena akuzindikira kuthekera kwa semaglutide kuthana ndi mliri wa kunenepa kwambiri.Bungwe la European Commission lapereka chilolezo cha malonda ku semaglutide pofuna kuchiza kunenepa kwambiri, ndi zilolezo zowonjezera zomwe zikuyembekezeredwa m'misika yosiyanasiyana yapadziko lonse.Kuzindikirika kofala komanso kukhazikitsidwa kwa semaglutide pakuchepetsa thupi kumalimbitsanso udindo wake monga wofunikira kwambiri pamsika wapadziko lonse wochepetsa thupi.

Pamene msika wapadziko lonse wa zosakaniza zochepetsera thupi ukukulirakulira, ndikofunikira kuti makampani opanga mankhwala aziyika patsogolo pakupanga njira zotetezeka komanso zogwira mtima.Semaglutide yatsimikizira kuti imatha kulimbikitsa kuchepa thupi komanso kukonza thanzi la kagayidwe kachakudya, ndikupangitsa kuti ikhale yokhazikika kuti ikwaniritse kufunikira kwazinthu zowongolera kulemera.Kupyolera mu kafukufuku wopitilira kafukufuku ndi ntchito zachitukuko, semaglutide ikuyembekezeka kutenga gawo lalikulu pothana ndi vuto la kunenepa kwambiri padziko lonse lapansi komanso kuthandiza anthu kukwaniritsa zolinga zawo zoonda.


Nthawi yotumiza: Dec-07-2023